- Home
- AUPH vs CEPU Comparison
AUPH vs CEPU Comparison
Compare AUPH & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- CEPU
- Stock Information
- Founded
- AUPH 1993
- CEPU 1989
- Country
- AUPH Canada
- CEPU Argentina
- Employees
- AUPH N/A
- CEPU N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- CEPU Electric Utilities: Central
- Sector
- AUPH Health Care
- CEPU Utilities
- Exchange
- AUPH Nasdaq
- CEPU Nasdaq
- Market Cap
- AUPH 1.6B
- CEPU 1.4B
- IPO Year
- AUPH 1999
- CEPU 2018
- Fundamental
- Price
- AUPH $13.17
- CEPU $16.35
- Analyst Decision
- AUPH Strong Buy
- CEPU Strong Buy
- Analyst Count
- AUPH 2
- CEPU 1
- Target Price
- AUPH $13.00
- CEPU $17.50
- AVG Volume (30 Days)
- AUPH 1.3M
- CEPU 653.6K
- Earning Date
- AUPH 11-04-2025
- CEPU 11-12-2025
- Dividend Yield
- AUPH N/A
- CEPU 1.90%
- EPS Growth
- AUPH N/A
- CEPU N/A
- EPS
- AUPH 0.42
- CEPU 0.12
- Revenue
- AUPH $260,111,000.00
- CEPU $628,806,380.00
- Revenue This Year
- AUPH $17.33
- CEPU $11.09
- Revenue Next Year
- AUPH $14.31
- CEPU $10.25
- P/E Ratio
- AUPH $31.33
- CEPU $16.92
- Revenue Growth
- AUPH 25.59
- CEPU N/A
- 52 Week Low
- AUPH $6.55
- CEPU $7.43
- 52 Week High
- AUPH $13.54
- CEPU $16.60
- Technical
- Relative Strength Index (RSI)
- AUPH 65.73
- CEPU 82.00
- Support Level
- AUPH $11.96
- CEPU $13.66
- Resistance Level
- AUPH $12.70
- CEPU $14.89
- Average True Range (ATR)
- AUPH 0.47
- CEPU 0.95
- MACD
- AUPH 0.17
- CEPU 0.77
- Stochastic Oscillator
- AUPH 85.96
- CEPU 97.62
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.